Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Poster: Optimization Study – Differentiating pancreatic cancer from individuals with concerning symptoms, including type II diabetes

January 1, 2021

Payam Delfani, Anders Carlsson, Thomas King, Randall Brand, Alexander Ney, Stephen P Pereira, Linda Dexlin Mellby

The IMMray™ PanCan-d optimization study was finalized 2019.

Click here to read the complete poster (pdf), Jan 2021